Log in
Enquire now
‌

US Patent 9610346 Recombinant viral vectors

Patent 9610346 was granted and assigned to International AIDS Vaccine Initiative on April, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Currently, there are no issues on this topic.

Find more entities like US Patent 9610346 Recombinant viral vectors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.